際際滷

際際滷Share a Scribd company logo
Principles of quality control of
  registered medicines, non-
   registered medicines and
counterfeits of medical products
                   Jean-Marc Spieser,
   Head of Department of Biological Standardisation, OMCL
              Network & HealthCare (DBO),
            EDQM/ Council of Europe, Strasbourg
Content
   EDQM  General Background
   Legal environment of registered medicines
   Tools available for the quality control of registered medicines
   The case of non-registered medicines and their vast
    environment
   How to control non-registered products
   Counterfeits of medical products
   How, why, and where it happens
   How to control it


     Jean-Marc Spieser, 23/09/09
     息2009 EDQM, Council of Europe, All rights reserved   2
The Council of Europe
  Founded in 1949
  Development of European common and democratic
   principles
  47 member countries
  Strasbourg




  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   3
The Council of Europe
  Founded in 1949
  Development of European
   common and democratic
   principles
  47 member countries
  Strasbourg




      European Convention on Human Rights
      (protection of individuals) &
      European Court of Human Rights

  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   4
Jean-Marc Spieser, 23/09/09
息2009 EDQM, Council of Europe, All rights reserved   5
The European Union




   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   6
EDQM - Short History
  1964:
       Convention on the Elaboration of a European
        Pharmacopoeia signed by 8 Member States
  1992:
       1st co-operation contract with the EU Commission on the
        Biological Standardisation Programme
  1994:
       European Community signs the Convention
       CEP  Implementation of the Certification of Suitability
        scheme
       Official Medicines Control Laboratory (OMCL)  Creation of
        the Network
   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   7
Short History
    Change of name: the Secretariat of the
    European Pharmacopoeia becomes the
    European Department (and later
    Directorate) for the Quality of Medicines
    (and later & HealthCare)



   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   8
Progressive Transfer of Activities
2007  Blood Transfusion and Organ
       Transplantation
2008  Pharmaceuticals and Pharmaceutical

       Care (general pharmaceutical
       activities)
2009  Cosmetics and Food Packaging
  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   9
Ph.Eur.+ Eur. Observers




   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   10
In the World




 Jean-Marc Spieser, 23/09/09
 息2009 EDQM, Council of Europe, All rights reserved   11
European Directorate for the Quality of
Medicines & HealthCare (EDQM)
Mission: to contribute to the basic human right
         of access to good quality medicines
         and healthcare

 Health is a social human right indispensable
 for the exercise of all other human rights, for
 prosperity and democratic stability of people
 in Europe

  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   12
European Directorate for the Quality of
      Medicines & HealthCare




  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   13
European Regulatory Network
                                             European Authorities
European Union
                                                    European Union

                                                                                                        European
                                                  Council   Parliament                               Medicines Agency
                                                      Commission                                      EMEALondon
                                                     DG Entreprise
                                                        Brussels
Council
of Europe                                           Pharmaceuticals
                                                                            EuropeanDirectorate       Ph. Eur.**
                                                   Pharmaceutical care
                                                                               for the Quality
*OMCL :Official Medicines Control                                        of Medicines & HealthCare
Laboratories                                      Blood Transfusion                                  Certification***
**Ph.Eur : European Pharmacopoeia
***Certification : Certification of Suitability                                  EDQM
of Monographs of the European
Pharmacopoeia                                        Organ Transplantation     Strasbourg            OMCL*
                                                                                                     Network
                          Jean-Marc Spieser, 23/09/09
                          息2009 EDQM, Council of Europe, All rights reserved                                       14
Quality Assurance
Quality is obtained through the combination of:
 Definition and concept of the product based on development
  work
 Good manufacturing processes steadily under control
   - starting, in-process and final controls
   - continuous optimisation
   - VALIDATED controls of the final product based on
     suitable and appropriate limited testing (necessary and
     fully sufficient),
                   All the above should be totally traceable

   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved          15
Quality Assurance
As a general concept

                                  QUALITY
 is manufactured and not only
          controlled

  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   16
Quality Control
QC Principles
   Laboratory of high quality
        Good equipment: validated, regularly
         maintained
        Good reagents
        Good operators



  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   17
Quality Control
QC Principles
   Working environment
                  QA/QMS in place
                  Good reporting
                  Procedures
                  PTS
                  Follow up and corrective actions
                  Procedures in place
                  Training
  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   18
Regulations
 Medicines are submitted to very strict
  regulations
 Each individual preparation requires a
  Marketing Authorisation (MA)




  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   19
Regulations
A fully detailed registration dossier is filed
based on:
Quality  Production using appropriate
process, suitable ingredients controlled and
released by validated tests
Safety - toxicology and pharmacology
Efficacy  clinical

   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   20
Regulations
All information and documentation
compiled by producers and/or authorised
importer are filed to Health Authorities in
accordance with legal procedures and
assessed by experts using defined rules
                      Official Authorisation

  Jean-Marc Spieser, 23/09/09
  息2009 EDQM, Council of Europe, All rights reserved   21
Regulations
 The product is continually assessed
  throughout its lifetime:
 Inspections
 Controls
         through laboratory testing
 Pharmacovigilance

If non-conformities are found  administrative, legal
              and/or financial penalities


   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   22
Tools
 The MAA: QA part
 CTD part
 Pharmacopoeias such as National Pharmacopoeias, International
  Pharmacopoeias, Ph. Eur., USP
- General Chapters
- Individual Monographs
 Guidelines/ aide m辿moire for inspections, sampling
 Literature/ data


   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   23
Sampling
 Ensure representativity
- withdrawn by authority or mandated persons
- not by manufacturer
- define place where samples are taken, how and how much

 Ensure good storage
- temperature
- humidity
- transportation


    Jean-Marc Spieser, 23/09/09
    息2009 EDQM, Council of Europe, All rights reserved   24
Non registered medicines
 Traditional origin
- Mostly oral and very restricted data available
- Origin not always traceable but should be
- How to control the claims and attributes given to these
  products
- What to control, which criteria and indicative parameters

 Legal environment??


    Jean-Marc Spieser, 23/09/09
    息2009 EDQM, Council of Europe, All rights reserved   25
Non registered medicines
 Controls
- Based on visual recognition of the substance or the plant
- If plant is chopped or ground use of of organoleptic
  properties, microscopic aspect and basic wet chemistry(test
  tube ) assays
- Important to verify that the right species is there
- Need of specialists




    Jean-Marc Spieser, 23/09/09
    息2009 EDQM, Council of Europe, All rights reserved   26
Non registered medicines
 Controls
- Based on traditional knowledge
- Sometimes described in literature bust mostly oral
- No official standards but need to develop it in known
  recognised compendia


- Be carefull on adulterated, counterfeits
- ILLEGAL


    Jean-Marc Spieser, 23/09/09
    息2009 EDQM, Council of Europe, All rights reserved    27
COUNTERFEITED MEDICINES
 By definition not known
 When and where it will happen


- ILLEGAL of course by defition

- 2 basic areas attacked
  - Blockbusters, expensive, well known, attractive.organised crime
  - Local , smallsmugglers for small quantities of every possible things

   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved         28
COUNTERFEITED MEDICINES
 How to combat these products
- Through multisectorial surveillance
  - Forensic analysis
  - Custom vigilance
  - Police controls




   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   29
COUNTERFEITED MEDICINES
 To start with
   Visual check of packaging very important


 Followed by analysis
   Simple and more and more sophisticated


 Need to have comparator
   Reference substance(s)
   Authentic samples



   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved   30
COUNTERFEITED MEDICINES
 Simple comparative tests

 Then sophisticated
   HPLC using different detectors, coupled with mass spectrum


 Usefulness of network



   Jean-Marc Spieser, 23/09/09
   息2009 EDQM, Council of Europe, All rights reserved       31
Thank you!
Jean-Marc Spieser, 23/09/09
息2009 EDQM, Council of Europe, All rights reserved   32
Ad

Recommended

EDQM - Overview of our products and services (2016)
EDQM - Overview of our products and services (2016)
Council of Europe (CoE)
European pharmacopoeia
European pharmacopoeia
Ilma Nurhidayati
Clinical trial regulation in eu
Clinical trial regulation in eu
Khushboo Bhatia
Emea
Emea
Ranjeet Singh
141203_MS_pharma_regulation
141203_MS_pharma_regulation
Francois-Xavier LERY
EU Food Regulation on Additives, Novel Foods and Food Contact Materials
EU Food Regulation on Additives, Novel Foods and Food Contact Materials
Daniele Pisanello
EU Regulatory Approach to GM Foods
EU Regulatory Approach to GM Foods
Ksenia Petrovets
EU Food Regulation - Where has Europe Got It Right and Why
EU Food Regulation - Where has Europe Got It Right and Why
Asian Food Regulation Information Service
Anteprima Pianificazione strategica per gli studi professionali della Guida a...
Anteprima Pianificazione strategica per gli studi professionali della Guida a...
eAgisco
Mike baker Aprende
Mike Baker Ovarb
Thais 5 a単os
1130626407
Set2011
tomarterratemplaria
Anti virus
Anti virus
Ajit Kumar Pradhan
Pratibimb october2012
Pratibimb october2012
Kashif Haider
1. scenario pembelajaran uk 2012
1. scenario pembelajaran uk 2012
sugainanaf
OpenText Learning Solutions
OpenText Learning Solutions
jaylambert
Instructional Methods Paper Power Point 2
Instructional Methods Paper Power Point 2
perezedaisyrn
Gesture recognition1
Gesture recognition1
Gaganveer Singh
ISUS Presentation v1403 en
ISUS Presentation v1403 en
michaelhandforth
Guida studente 2012 2013
Guida studente 2012 2013
University of Teramo
Dreamworks
Dreamworks
russian21
Atiati
Atiati
Koyo Yamamori
Academic excellence rti
Academic excellence rti
srichrds
C董m tr畛n th畉p c畉m ki畛u m畛i
C董m tr畛n th畉p c畉m ki畛u m畛i
C叩c M坦n n Ngon
Introduction law III Class
Introduction law III Class
Xavier V叩zquez Dom鱈nguez
Ag.2011
tomarterratemplaria
Regulatory requirement for europe union
Regulatory requirement for europe union
ShresthaPandey1
Regulatory Requirement for European Union Countries.pptx
Regulatory Requirement for European Union Countries.pptx
ArindamGhosh828861

More Related Content

Viewers also liked (20)

Anteprima Pianificazione strategica per gli studi professionali della Guida a...
Anteprima Pianificazione strategica per gli studi professionali della Guida a...
eAgisco
Mike baker Aprende
Mike Baker Ovarb
Thais 5 a単os
1130626407
Set2011
tomarterratemplaria
Anti virus
Anti virus
Ajit Kumar Pradhan
Pratibimb october2012
Pratibimb october2012
Kashif Haider
1. scenario pembelajaran uk 2012
1. scenario pembelajaran uk 2012
sugainanaf
OpenText Learning Solutions
OpenText Learning Solutions
jaylambert
Instructional Methods Paper Power Point 2
Instructional Methods Paper Power Point 2
perezedaisyrn
Gesture recognition1
Gesture recognition1
Gaganveer Singh
ISUS Presentation v1403 en
ISUS Presentation v1403 en
michaelhandforth
Guida studente 2012 2013
Guida studente 2012 2013
University of Teramo
Dreamworks
Dreamworks
russian21
Atiati
Atiati
Koyo Yamamori
Academic excellence rti
Academic excellence rti
srichrds
C董m tr畛n th畉p c畉m ki畛u m畛i
C董m tr畛n th畉p c畉m ki畛u m畛i
C叩c M坦n n Ngon
Introduction law III Class
Introduction law III Class
Xavier V叩zquez Dom鱈nguez
Ag.2011
tomarterratemplaria
Anteprima Pianificazione strategica per gli studi professionali della Guida a...
Anteprima Pianificazione strategica per gli studi professionali della Guida a...
eAgisco
Mike baker Aprende
Mike Baker Ovarb
Thais 5 a単os
1130626407
Pratibimb october2012
Pratibimb october2012
Kashif Haider
1. scenario pembelajaran uk 2012
1. scenario pembelajaran uk 2012
sugainanaf
OpenText Learning Solutions
OpenText Learning Solutions
jaylambert
Instructional Methods Paper Power Point 2
Instructional Methods Paper Power Point 2
perezedaisyrn
ISUS Presentation v1403 en
ISUS Presentation v1403 en
michaelhandforth
Dreamworks
Dreamworks
russian21
Academic excellence rti
Academic excellence rti
srichrds
C董m tr畛n th畉p c畉m ki畛u m畛i
C董m tr畛n th畉p c畉m ki畛u m畛i
C叩c M坦n n Ngon

Similar to 1 1 quality-principles (20)

Regulatory requirement for europe union
Regulatory requirement for europe union
ShresthaPandey1
Regulatory Requirement for European Union Countries.pptx
Regulatory Requirement for European Union Countries.pptx
ArindamGhosh828861
EUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptx
PrachiSharma575050
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
datchayani
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
Michael Bonett
The EU system for marketing authorization
The EU system for marketing authorization
ShreyaKumar62
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Council of Europe (CoE)
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
BharatRRDesai
The Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified Medicines
European Industrial Pharmacists Group
Marketing authorisations in the European Union
Marketing authorisations in the European Union
Francois MAIGNEN
Marketing Authorisations in the EU: The Centralised Procedure
Marketing Authorisations in the EU: The Centralised Procedure
Office of Health Economics
Regulatory requirments of eu, tga & row countries
Regulatory requirments of eu, tga & row countries
GeetaKhillari
BioAsia Ms. Mandisa Hela - South Africa
BioAsia Ms. Mandisa Hela - South Africa
BioAsia: The Global Bio Business Forum
Presentation on EU Regulatory & Quality System.
Presentation on EU Regulatory & Quality System.
GMP EDUCATION : Not for Profit Organization
REGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptx
ShivamKumar740
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
Dhruvi Panchal
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptx
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptx
Mayur Patil
European Medicines Agency (EMA) and the Medicines and Healthcare products Reg...
European Medicines Agency (EMA) and the Medicines and Healthcare products Reg...
Shiva G S
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
Himal Barakoti
Regulatory requirement of EU, TGA, MHRA, and ROW countries
Regulatory requirement of EU, TGA, MHRA, and ROW countries
singhbaghelh3
Regulatory requirement for europe union
Regulatory requirement for europe union
ShresthaPandey1
Regulatory Requirement for European Union Countries.pptx
Regulatory Requirement for European Union Countries.pptx
ArindamGhosh828861
EUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptx
PrachiSharma575050
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
datchayani
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
1 MB 20 DEC 2016 CV - GMP GDP QMS ISO 9001 13485 PV RA
Michael Bonett
The EU system for marketing authorization
The EU system for marketing authorization
ShreyaKumar62
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Annual report 2015 - European Directorate for the Quality of Medicines & Heal...
Council of Europe (CoE)
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW COUNTRIES.pptx
BharatRRDesai
The Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified Medicines
European Industrial Pharmacists Group
Marketing authorisations in the European Union
Marketing authorisations in the European Union
Francois MAIGNEN
Marketing Authorisations in the EU: The Centralised Procedure
Marketing Authorisations in the EU: The Centralised Procedure
Office of Health Economics
Regulatory requirments of eu, tga & row countries
Regulatory requirments of eu, tga & row countries
GeetaKhillari
REGULATION OF EU BY SHIVAM.pptx
REGULATION OF EU BY SHIVAM.pptx
ShivamKumar740
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
Dhruvi Panchal
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptx
CLINICAL_RESEARCH_REGULATIONS_IN_EUROPIAN_UNION_(_EMA[1] - Read-Only.pptx
Mayur Patil
European Medicines Agency (EMA) and the Medicines and Healthcare products Reg...
European Medicines Agency (EMA) and the Medicines and Healthcare products Reg...
Shiva G S
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
Himal Barakoti
Regulatory requirement of EU, TGA, MHRA, and ROW countries
Regulatory requirement of EU, TGA, MHRA, and ROW countries
singhbaghelh3
Ad

1 1 quality-principles

  • 1. Principles of quality control of registered medicines, non- registered medicines and counterfeits of medical products Jean-Marc Spieser, Head of Department of Biological Standardisation, OMCL Network & HealthCare (DBO), EDQM/ Council of Europe, Strasbourg
  • 2. Content EDQM General Background Legal environment of registered medicines Tools available for the quality control of registered medicines The case of non-registered medicines and their vast environment How to control non-registered products Counterfeits of medical products How, why, and where it happens How to control it Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 2
  • 3. The Council of Europe Founded in 1949 Development of European common and democratic principles 47 member countries Strasbourg Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 3
  • 4. The Council of Europe Founded in 1949 Development of European common and democratic principles 47 member countries Strasbourg European Convention on Human Rights (protection of individuals) & European Court of Human Rights Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 4
  • 5. Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 5
  • 6. The European Union Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 6
  • 7. EDQM - Short History 1964: Convention on the Elaboration of a European Pharmacopoeia signed by 8 Member States 1992: 1st co-operation contract with the EU Commission on the Biological Standardisation Programme 1994: European Community signs the Convention CEP Implementation of the Certification of Suitability scheme Official Medicines Control Laboratory (OMCL) Creation of the Network Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 7
  • 8. Short History Change of name: the Secretariat of the European Pharmacopoeia becomes the European Department (and later Directorate) for the Quality of Medicines (and later & HealthCare) Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 8
  • 9. Progressive Transfer of Activities 2007 Blood Transfusion and Organ Transplantation 2008 Pharmaceuticals and Pharmaceutical Care (general pharmaceutical activities) 2009 Cosmetics and Food Packaging Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 9
  • 10. Ph.Eur.+ Eur. Observers Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 10
  • 11. In the World Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 11
  • 12. European Directorate for the Quality of Medicines & HealthCare (EDQM) Mission: to contribute to the basic human right of access to good quality medicines and healthcare Health is a social human right indispensable for the exercise of all other human rights, for prosperity and democratic stability of people in Europe Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 12
  • 13. European Directorate for the Quality of Medicines & HealthCare Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 13
  • 14. European Regulatory Network European Authorities European Union European Union European Council Parliament Medicines Agency Commission EMEALondon DG Entreprise Brussels Council of Europe Pharmaceuticals EuropeanDirectorate Ph. Eur.** Pharmaceutical care for the Quality *OMCL :Official Medicines Control of Medicines & HealthCare Laboratories Blood Transfusion Certification*** **Ph.Eur : European Pharmacopoeia ***Certification : Certification of Suitability EDQM of Monographs of the European Pharmacopoeia Organ Transplantation Strasbourg OMCL* Network Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 14
  • 15. Quality Assurance Quality is obtained through the combination of: Definition and concept of the product based on development work Good manufacturing processes steadily under control - starting, in-process and final controls - continuous optimisation - VALIDATED controls of the final product based on suitable and appropriate limited testing (necessary and fully sufficient), All the above should be totally traceable Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 15
  • 16. Quality Assurance As a general concept QUALITY is manufactured and not only controlled Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 16
  • 17. Quality Control QC Principles Laboratory of high quality Good equipment: validated, regularly maintained Good reagents Good operators Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 17
  • 18. Quality Control QC Principles Working environment QA/QMS in place Good reporting Procedures PTS Follow up and corrective actions Procedures in place Training Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 18
  • 19. Regulations Medicines are submitted to very strict regulations Each individual preparation requires a Marketing Authorisation (MA) Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 19
  • 20. Regulations A fully detailed registration dossier is filed based on: Quality Production using appropriate process, suitable ingredients controlled and released by validated tests Safety - toxicology and pharmacology Efficacy clinical Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 20
  • 21. Regulations All information and documentation compiled by producers and/or authorised importer are filed to Health Authorities in accordance with legal procedures and assessed by experts using defined rules Official Authorisation Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 21
  • 22. Regulations The product is continually assessed throughout its lifetime: Inspections Controls through laboratory testing Pharmacovigilance If non-conformities are found administrative, legal and/or financial penalities Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 22
  • 23. Tools The MAA: QA part CTD part Pharmacopoeias such as National Pharmacopoeias, International Pharmacopoeias, Ph. Eur., USP - General Chapters - Individual Monographs Guidelines/ aide m辿moire for inspections, sampling Literature/ data Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 23
  • 24. Sampling Ensure representativity - withdrawn by authority or mandated persons - not by manufacturer - define place where samples are taken, how and how much Ensure good storage - temperature - humidity - transportation Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 24
  • 25. Non registered medicines Traditional origin - Mostly oral and very restricted data available - Origin not always traceable but should be - How to control the claims and attributes given to these products - What to control, which criteria and indicative parameters Legal environment?? Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 25
  • 26. Non registered medicines Controls - Based on visual recognition of the substance or the plant - If plant is chopped or ground use of of organoleptic properties, microscopic aspect and basic wet chemistry(test tube ) assays - Important to verify that the right species is there - Need of specialists Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 26
  • 27. Non registered medicines Controls - Based on traditional knowledge - Sometimes described in literature bust mostly oral - No official standards but need to develop it in known recognised compendia - Be carefull on adulterated, counterfeits - ILLEGAL Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 27
  • 28. COUNTERFEITED MEDICINES By definition not known When and where it will happen - ILLEGAL of course by defition - 2 basic areas attacked - Blockbusters, expensive, well known, attractive.organised crime - Local , smallsmugglers for small quantities of every possible things Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 28
  • 29. COUNTERFEITED MEDICINES How to combat these products - Through multisectorial surveillance - Forensic analysis - Custom vigilance - Police controls Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 29
  • 30. COUNTERFEITED MEDICINES To start with Visual check of packaging very important Followed by analysis Simple and more and more sophisticated Need to have comparator Reference substance(s) Authentic samples Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 30
  • 31. COUNTERFEITED MEDICINES Simple comparative tests Then sophisticated HPLC using different detectors, coupled with mass spectrum Usefulness of network Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 31
  • 32. Thank you! Jean-Marc Spieser, 23/09/09 息2009 EDQM, Council of Europe, All rights reserved 32